OOIR: Observatory of International Research

Papers

(The H4-Index of British Journal of Cancer is 56. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Advancing radiomics from contrast-enhanced mammography in breast cancer	232
The EXO1/Polη/Polι axis as a promising target for miR-3163-mediated attenuation of cancer stem-like cells in non-small cell lung carcinoma	184
Years of life lost due to cancer in the United Kingdom from 1988 to 2017	168
Proactive breast cancer risk assessment in primary care: a review based on the principles of screening	154
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study)	153
Correction: YY1 targets tubulin polymerisation-promoting protein to inhibit migration, invasion and angiogenesis in pancreatic cancer via p38/MAPK and PI3K/AKT pathways	144
Correction: Wnt/ERK/CDK4/6 activation in the partial EMT state coordinates mammary cancer stemness with self-renewal and inhibition of differentiation	142
Extranodal extension in lung adenocarcinoma: pathological insights and its implication as a histological marker of clinical aggressiveness	139
Capecitabine combined with immunotherapy as maintenance therapy improves survival in recurrent/metastatic nasopharyngeal carcinoma: a retrospective cohort study	136
Correction to: Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells	135
PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer	126
Mismatch repair markers in preoperative and operative endometrial cancer samples; expression concordance and prognostic value	124
Neoplasm risk in individuals with neurofibromatosis 1 – a Danish nationwide cohort study with long-term follow-up	121
Extruded small extracellular vesicles: splinters of circulating tumour cells may promote cancer metastasis?	117
Diagnostic accuracy of combinatorial mRNA biomarkers for non-invasive detection and therapy monitoring of oral and oropharyngeal SCC	113
Correction To: Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial	103
Hit it hard: qualitative patient perspectives on the optimisation of immune checkpoint inhibition	102
Genetic landscape of stage II melanoma identifies CBL as a new driver gene and prognostic biomarker	100
Surveillance after childhood cancer: are survivors with an increased risk for cardiomyopathy regularly followed-up?	99
Investigation of the gut microbiome, bile acid composition and host immunoinflammatory response in a model of azoxymethane-induced colon cancer at discrete timepoints	99
A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasms	98
Abemaciclib plus fulvestrant in treating hormone-receptor positive, HER2-negative advanced breast cancer—comparing real-world outcomes in England to the MONARCH-2 trial	97
Advances in cancer immunotherapy: adoptive cell therapy and immune cell engagers in solid tumours	94
Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physicians	93
Hepatitis B virus X protein promotes MAN1B1 expression by enhancing stability of GRP78 via TRIM25 to facilitate hepatocarcinogenesis	87

Navigating therapeutic strategies: HPV classification in head and neck cancer	85
Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers	85
Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025)	83
Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity	82
Genomic ALK alterations in primary and relapsed neuroblastoma	80
Romiplostim for chemotherapy induced thrombocytopenia in pediatric cancers	78
Assessments of social vulnerability on laryngeal cancer treatment & prognosis in the US	78
Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer	77
DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma	75
Metastasis-associated fibroblasts in peritoneal surface malignancies	73
Breast cancer risk prediction with a modified BOADICEA model in Danish women	73
Normal weight obesity, circulating biomarkers and risk of breast cancer: a prospective cohort study and meta-analysis	72
Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: a matter of debate	72
Primary tumor sidedness and negative hyperselection to modulate anti-EGFR-based maintenance strategies in patients with RAS wild-type metastatic colorectal cancer: individual patient data pooled analy	71
Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities	70
Metabolic adaptations in prostate cancer	69
The prognostic and biology of tumour-infiltrating lymphocytes in the immunotherapy of cancer	67
Clarifying causal and translational inference in studies of ambient PM2.5 and lung cancer	64
Somatic hits in mismatch repair genes in colorectal cancer among non-seminoma testicular cancer survivors	63
Risk-based breast cancer screening	63
Evidence into practice: a national cohort study of NICE-recommended oncological drug therapy utilisation among women diagnosed with invasive breast cancer in England	62
The HLA ligandome of oropharyngeal squamous cell carcinomas reveals shared tumour-exclusive peptides for semi-personalised vaccination	61
Long-term trends in incidence, characteristics and prognosis of screen-detected and interval cancers in women participating in the Dutch breast cancer screening programme	61
Progress and priorities in reducing the time to cancer diagnosis	61
Serum 25-hydroxyvitamin D concentrations and colorectal cancer incidence in adults with type 2 diabetes	61
Relation knowledge distillation 3D-ResNet-based deep learning for breast cancer molecular subtypes prediction on ultrasound videos: a multicenter study	61
Identification of increased dedifferentiation along the Prom1+ cancer cells in Müllerian adenosarcoma with sarcomatous overgrowth	61
Protein markers of ovarian cancer and its subtypes: insights from proteome-wide Mendelian randomisation analysis	59
Contralateral breast cancer after radiotherapy and hormone therapy in two cohorts of US breast cancer survivors	58
Hypoxia- and Postirradiation reoxygenation-induced HMHA1/ARHGAP45 expression contributes to cancer cell invasion in a HIF-dependent manner	57
Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial	57